Non-relapsing Secondary Progressive Multiple Sclerosis Clinical Trials

Non-relapsing Secondary Progressive Multiple Sclerosis

Explore clinical trials studying Non-relapsing Secondary Progressive Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Non-relapsing Secondary Progressive Multiple Sclerosis trial results

Completed

Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)

NCT04411641

Conditions: Non-relapsing Secondary Progressive Multiple Sclerosis
Locations: University of Alabama MS Center-Site Number:8400013 Birmingham, Alabama, United States

Center for Neurology and Spine-Site Number:8400089 Phoenix, Arizona, United States

Arcadia Neurology Center-Site Number:8400070 Arcadia, California, United States

UC San Diego ACTRI-Site Number:8400101 La Jolla, California, United States

View all 306 locations

View Trial Details